Codexis, Inc. is a biotechnology company that develops enzymes for use in pharmaceuticals, biofuels, and other industrial applications. The company's products include enzymes used in the production of pharmaceuticals, as well as enzymes used in the production of biofuels and other industrial chemicals. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California. The company has operations in several countries, including the United States, the United Kingdom, and Singapore. Codexis, Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol CDXS.